| abstract |
This invention relates to a compound represented by formula (I), or salt, N-oxide, solvate or prodrug thereof (symbols in the formula are defined as same as specification). The compound of this invention has CXCR4 antagonism for use of preventing and/or therapeutic agent or regeneration medical agent for CXCR4-mediated diseases such as inflammatory, immune disease (such as rheumatoid arthritis, arthritis, retinopathy, pulmonary fibrosis, rejection response of transplant organ and the like), hypersensitive disease, infectious disease (such as infection of human immunodeficiency virus, acquired immune deficiency syndrome and the like), mental/ neurotic disease, brain disease, cardiovascular disease, metabolic disease, cancer disease (such as cancer, metastasis and the like) and the like. |